OB-GYN-L Messages for May, 2003: Re: Cytotec Revisited

Re: Cytotec Revisited
From: art fougner, md (evsono@pipeline.com)
Wed May 7 16:05:13 2003

Messages sorted by: [ date ][ thread ][ subject ][ author ]
Next message: Garry E. Siegel, M.D.: "Re: Family Practice Consultation Guidelines"
Previous message: Myer Bornstein: "Re: Cytotec Revisited"

Myer
was referenced in the May Green Journal
art
At Wed, 7 May 2003, Myer Bornstein wrote: >
>No, and I could not find anything new on the FDA site
>
>Myer
>
>-----Original Message-----
>From: ob-gyn-l@obgyn.net [mailto:ob-gyn-l@obgyn.net] On Behalf Of art
>fougner, md
>Sent: Wednesday, May 07, 2003 3:56 PM
>To: Multiple recipients of list OB-GYN-L
>Subject: OB: Cytotec Revisited
>
>anyone get a chance to review the new FDA labeling on cytotec (
>misoprostol) in pregnancy?
>
>art
>
>--
>art fougner, md
>ich bin ein New Yorker
>

-- art fougner, md ich bin ein New Yorker

Next message: Garry E. Siegel, M.D.: "Re: Family Practice Consultation Guidelines"
Previous message: Myer Bornstein: "Re: Cytotec Revisited"

Return to Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Mon Nov 2 04:53:37 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.

use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
	Returns per screen: Require all keywords: